Centessa Pharmaceuticals
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Centessa Pharmaceuticals's balance sheet done over the years? Its assets were worth $360,246,000 last year, which is less than in the previous period. 34% of Centessa Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $124,002,000, which means an increase by 15% compared compared to last year.

Debt to Assets

Centessa Pharmaceuticals plc (NASDAQ:CNTA): Debt to assets
2020 11717000 34.14M 291.37%
2021 629635000 138.08M 21.93%
2022 444307000 108.13M 24.34%
2023 360246000 124.00M 34.42%

CNTA Balance Sheet (2020 – 2023)

2023 2022 2021 2020
Assets
Current assets:
Cash and cash equivalents
128.03M393.64M595.08M7.22M
Short term investments
128.51M000
Net receivables
39.14M26.72M16.81M2.93M
Inventory
1-29.99M-17.80M1.00M
Other current assets
19.39M3.27M993K6K
Total current assets
315.09M393.64M595.08M11.16M
Non-current assets:
Property, Plant and Equipment
12.95M1.16M162K0
Goodwill
0000
Intangible assets
0000
Long term investments
0000
Other non-current assets
2.55M45.98M34.39M552K
Total non-current assets
45.15M50.66M34.55M552K
Total assets
360.24M444.30M629.63M11.71M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
0001.03M
Short term debt
0005.62M
Total current liabilities
39.38M38.33M24.63M8.61M
Non-current liabilities:
Long term debt
84.58M69.8M75.7M0
Deferred tax
0000
Other non-current liabilities
29K38.33M62.38M0
Total non-current liabilities
84.61M108.13M138.08M25.52M
Total liabilities
124.00M108.13M138.08M34.14M
Data sourceData sourceData source